Advanced Enzyme Technologies Bilan de santé
Santé financière contrôle des critères 6/6
Advanced Enzyme Technologies possède un total de capitaux propres de ₹13.9B et une dette totale de ₹256.9M, ce qui porte son ratio d'endettement à 1.8%. Son actif total et son passif total sont ₹15.5B et de ₹1.6B. L'EBIT de Advanced Enzyme Technologies est ₹1.7B ce qui fait que son ratio de couverture des intérêts -16.8. Elle dispose de liquidités et de placements à court terme de ₹5.1B.
Informations clés
1.8%
Ratio d'endettement
₹256.89m
Dette
| Ratio de couverture des intérêts | -16.8x |
| Argent liquide | ₹5.07b |
| Fonds propres | ₹13.89b |
| Total du passif | ₹1.60b |
| Total des actifs | ₹15.49b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Analyse de la situation financière
Passif à court terme: Les actifs à court terme de ADVENZYMES ( ₹8.1B ) dépassent ses passifs à court terme ( ₹1.0B ).
Passif à long terme: Les actifs à court terme de ADVENZYMES ( ₹8.1B ) dépassent ses passifs à long terme ( ₹564.4M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: ADVENZYMES dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de ADVENZYMES a été réduit de 2.5% à 1.8% au cours des 5 dernières années.
Couverture de la dette: La dette de ADVENZYMES est bien couverte par le flux de trésorerie opérationnel ( 553.6% ).
Couverture des intérêts: ADVENZYMES gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.